P 
65.03
-0.63%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$1.73bn
FY2016FY2025
Net income
$682.6m
FY2016FY2025
Free cash flow
$411.2m
FY2016FY2025
Shareholders' equity
−$205.3m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.73bn | $806.8m | $937.8m | $698.8m | $538.6m | $380.8m | $307.0m | $264.7m | $194.4m | $82.7m |
| Gross profit | $1.66bn | $749.4m | $872.3m | $654.1m | $506.3m | $361.8m | $294.8m | $252.1m | $189.8m | $82.7m |
| Research and development | $455.2m | $534.5m | $666.6m | $651.5m | $540.7m | $477.6m | $257.5m | $172.0m | $117.5m | $117.6m |
| Operating income | $856.5m | −$196.1m | −$566.9m | −$496.6m | −$432.3m | −$431.8m | −$241.2m | −$115.6m | −$65.6m | −$133.3m |
| Net income | $682.6m | −$363.3m | −$626.6m | −$559.0m | −$523.9m | −$438.2m | −$251.6m | −$128.1m | −$79.0m | −$142.1m |
| Diluted earnings per share | 8.46 | -4.71 | -8.30 | -7.69 | -7.41 | -6.56 | -4.45 | -2.54 | -1.88 | -4.16 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.90bn | $1.71bn | $1.90bn | $1.71bn | $1.94bn | $2.21bn | $1.62bn | $1.12bn | $391.7m | $269.3m |
| Cash and short-term investments | $1.95bn | $1.14bn | $876.7m | $410.7m | $773.4m | $1.10bn | $686.6m | $227.6m | $191.2m | $231.7m |
| Total liabilities | $3.10bn | $2.80bn | $2.71bn | $2.05bn | $1.94bn | $1.73bn | $1.03bn | $768.5m | $235.2m | $149.8m |
| Debt | $2.61bn | $2.39bn | $2.12bn | $1.35bn | $1.19bn | $1.01bn | $313.9m | $153.0m | $145.0m | $98.2m |
| Shareholders' equity | −$205.3m | −$1.10bn | −$818.6m | −$347.1m | $1.4m | $482.0m | $594.3m | $350.7m | $156.4m | $119.6m |
| Shares outstanding | 81m | 77m | 76m | 73m | 71m | 67m | 57m | 50m | 42m | 34m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $711.2m | −$107.7m | −$158.4m | −$356.7m | −$251.3m | −$194.1m | −$98.6m | −$27.6m | −$10.1m | −$103.6m |
| Capital spending | −$300.0m | −$74.2m | −$120.6m | −$152.5m | −$85.3m | −$56.0m | −$45.4m | −$15.5m | −$3.1m | −$1.8m |
| Free cash flow | $411.2m | −$181.9m | −$279.0m | −$509.1m | −$336.7m | −$250.0m | −$144.1m | −$43.2m | −$13.2m | −$105.3m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $360.5m | $272.6m | $164.7m | $211.0m | $178.9m | $1.18bn | $213.2m | $196.8m |
| Gross profit | $340.6m | $244.5m | $148.4m | $95.1m | $167.5m | $1.16bn | $196.9m | $185.9m |
| Operating income | $146.0m | $45.9m | −$81.6m | $3.0m | −$40.7m | $970.2m | −$53.6m | −$56.4m |
| Net income | $83.5m | −$2.8m | −$135.0m | $15.9m | −$64.8m | $866.6m | −$65.9m | −$106.7m |
| Diluted earnings per share | 0.91 | -0.03 | -1.67 | 0.20 | -0.80 | 10.74 | -0.85 | -1.38 |
| Cash from operations | $129.0m | −$59.0m | −$34.0m | −$66.0m | −$58.0m | $870.0m | −$30.0m | −$76.0m |
| Capital spending | −$7.0m | −$1.0m | −$37.0m | −$256.0m | −$3.0m | −$2.0m | −$6.0m | −$10.0m |
| Free cash flow | $122.0m | −$60.0m | −$71.0m | −$322.0m | −$61.0m | $868.0m | −$36.0m | −$86.0m |
| Total assets | $3.25bn | $2.87bn | $2.90bn | $2.64bn | $2.63bn | $2.66bn | $1.71bn | $1.84bn |
| Cash and short-term investments | $2.23bn | $1.89bn | $1.95bn | $1.69bn | $1.99bn | $2.03bn | $1.14bn | $1.01bn |
| Debt | $608.9m | $305.0m | $2.61bn | $300.8m | $303.1m | $302.2m | $2.38bn | $301.9m |
| Shareholders' equity | −$165.4m | −$180.5m | −$205.3m | −$155.8m | −$206.5m | −$185.8m | −$1.10bn | −$1.05bn |
Financial ratios
Data as of 14 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 95.9% | 92.9% | 93.0% | 93.6% | 94.0% | 95.0% |
| Operating margin | 49.0% | -24.3% | -60.5% | -71.1% | -80.3% | -91.0% |
| Net margin | 39.4% | -45.0% | -66.8% | -80.0% | -97.3% | -115.1% |
| Return on equity | -332.5% | 33.1% | 76.6% | 161.1% | -36432.6% | -90.9% |
| Return on assets | 23.5% | -21.3% | -33.1% | -32.8% | -27.0% | -19.8% |
| Free cash flow yield | 20.9% | -0.7% | -0.8% | -4.7% | -3.9% | -3.4% |
| Revenue growth | 114.5% | -14.0% | 34.2% | 29.7% | 41.4% | 24.0% |
| Earnings growth | -287.9% | -42.0% | 12.1% | 6.7% | 19.6% | 74.2% |
| Current ratio | 2.35x | 2.35x | 2.02x | 1.71x | 1.52x | 4.44x |
| Debt to equity | -12.71x | -2.17x | -2.58x | -1.89x | 307.17x | 0.66x |
| Equity ratio | -7.1% | -64.4% | -43.2% | -20.3% | 0.1% | 21.8% |
| Interest coverage | 5.58x | -1.17x | -4.39x | -5.47x | -5.03x | -6.15x |
| R&D as a share of sales | 26.3% | 66.2% | 71.1% | 93.2% | 100.4% | 125.4% |
| Buybacks as a share of market value | -4.5% | -2.2% | -3.9% | -2.8% | -5.7% | -18.1% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 35.3% | 35.4% | 47.0% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 94.9% | 94.3% | 94.3% | 94.6% |
| Operating margin | 26.0% | -9.7% | -24.9% | -33.3% |
| Net margin | 12.6% | -20.8% | -35.9% | -43.5% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 9.0 | -9.6 | -3.3 | -5.0 | -5.4 | -9.3 | -10.8 | -13.5 | -8.9 | -2.6 |
| Price to sales | 3.5 | 4.3 | 2.2 | 4.0 | 5.2 | 10.7 | 8.8 | 6.5 | 3.6 | 4.5 |
Market value over time
30 Nov 2016 to 13 Oct 2026, in USD
$378.8m$5.51bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 64% | 65% | -28% | -5% | -38% | 34% | 57% | 90% | 33% | 73% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.